Shree Ganesh Bio

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE051N01026
  • NSEID:
  • BSEID: 539470
INR
0.59
0.00 (0.00%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 2.49 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

No Fixed Assets in the last few periods;

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is -9.12% vs -81.20% in Mar 2024

Compare Balance Sheet Results of Shree Ganesh Bio
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
39.86
4.45
35.41
795.73%
Share Warrants & Outstandings
Total Reserve
23.39
-6.44
29.83
463.20%
Shareholder's Funds
63.26
-1.99
65.25
3,278.89%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
8.09
-8.09
-100.00%
Secured Loans
0.00
5.10
-5.10
-100.00%
Unsecured Loans
0.00
2.99
-2.99
-100.00%
Deferred Tax Assets / Liabilities
0.00
-0.19
0.19
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
7.51
-7.51
-100.00%
Current Liabilities
Trade Payables
0.00
10.22
-10.22
-100.00%
Other Current Liabilities
0.23
2.24
-2.01
-89.73%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.00
0.59
-0.59
-100.00%
Total Current Liabilities
0.23
13.04
-12.81
-98.24%
Total Liabilities
63.49
18.56
44.93
242.08%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.01
17.69
-17.68
-99.94%
Less: Accumulated Depreciation
0.01
9.72
-9.71
-99.90%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
7.97
-7.97
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
9.15
0.40
8.75
2,187.50%
Long Term Loans & Advances
50.94
0.18
50.76
28,200.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
60.09
8.56
51.53
601.99%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
2.89
3.31
-0.42
-12.69%
Sundry Debtors
0.00
1.28
-1.28
-100.00%
Cash and Bank
0.01
0.09
-0.08
-88.89%
Other Current Assets
0.49
0.00
0.49
0.00%
Short Term Loans and Advances
0.00
5.32
-5.32
-100.00%
Total Current Assets
3.39
10.00
-6.61
-66.10%
Net Current Assets (Including Current Investments)
3.16
-3.03
6.19
204.29%
Total Current Assets Excluding Current Investments
3.39
10.00
-6.61
-66.10%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
63.49
18.56
44.93
242.08%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
7.32
-7.32
-100.00%
Book Value per share (adjusted)
1.59
-4.47
6.06
135.57%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Markets Mojo
No Fixed Assets in the last few periods
stock-summary

No Fixed Assets in the last few periods;

Annual - Investments
Investments 9.15 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 3.39 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -9.12% vs -81.20% in Mar 2024